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SUMMARY. An HPTLC method for analysis of risedronate sodium in bulk and pharmaceutical formula-
tion has been established and validated. The analyte was separated on aluminium plates precoated with
silica gel 60 F254. The mobile phase was water-acetontrile-ammonia solution 9.3:0.40:0.3 (v/v). Quantifica-
tion was done by densitometric scanning at 262 nm. Response was a linear function of risedronate asdium
concentration in the range of 5 to 25 μg/mL. The limit of detection and quantification for risedronate sodi-
um were 0.86 and 3.03 μg/mL respectively. Average recovery of risedronate sodium was 99.31, which
shows that the method was free from interference from excipients present in the formulation. The estab-
lished method enabled accurate, precise, and rapid analysis of risedronate sodium in bulk as well as phar-
maceutical formulation.
